Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitroIC50 values predict SARS-CoV-2 neutralising antibody titres.

Saved in:
Bibliographic Details
Title: Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitroIC50 values predict SARS-CoV-2 neutralising antibody titres.
Authors: Clegg LE; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D AstraZeneca Gaithersburg MD USA., Stepanov O; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D AstraZeneca Cambridge UK., Matthews S; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Cambridge UK., White T; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Cambridge UK., Seegobin S; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Cambridge UK., Thomas S; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Durham NC USA., Tuffy KM; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Gaithersburg MD USA., Någård M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D AstraZeneca Gaithersburg MD USA., Esser MT; Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Gaithersburg MD USA., Streicher K; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Gaithersburg MD USA., Cohen TS; Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Gaithersburg MD USA., Aksyuk AA; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D AstraZeneca Gaithersburg MD USA.
Source: Clinical & translational immunology [Clin Transl Immunology] 2024 Jun 13; Vol. 13 (6), pp. e1517. Date of Electronic Publication: 2024 Jun 13 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2050-0068
DOI:10.1002/cti2.1517